| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.018 | 0.9 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |